PBM Capital Rx raises 106M; Virtual Surgery Platform Proximity Score $ 80M

A series C funding round led by Pharmacy Benefit Manager Capital RXB Capital raised $ 106 million. The round included participation from General Catalyst and existing investor Transformation Capital and Edison Partners. Capital RX says its total fundraiser is now a total of $ 175 million.

The company offers the JUDI platform, pharmacy benefit software which includes tools for planning and execution, claims processing, data exchange, pre-approval and billing.

B Capital’s general partner, Dr. Robert Mittendorf, said in a statement: “Capital Rx has the clearest vision we have seen in the market of how to enable healthcare infrastructure to be better cared for at a lower cost.” As part of the investment, Mittendorf will join the board of directors of Capital RX.

“AJ and the team have made incredible progress in modernizing and integrating operating platforms for prescription drug pricing and delivery, showing industry partners, employers and American consumers that access to and pricing of prescription drugs delivers a new level of care and patient experience.”


Virtual Surgery Platform Proximity announced Tuesday that it has raised $ 80 million in Series C funding.

The round was led by Advent Life Sciences with the participation of Emerson Collective, Softbank Vision Fund 2, British Patient Capital, Mubadala Investment Company and Mindaru Foundation. Current investors include F-Prime Capital, Eight Rhodes, Questa Capital, Global Ventures and Maverick Ventures.

The latest increase brings the company’s total funding to $ 130 million. Proximity recently made an announcement বি 38 million Series B in April 2021.

The startup uses augmented reality technology to allow physicians to be present from a distance and participate in surgery. Data from these methods can be recorded and analyzed later with a view to improving the results. Funding will go towards the development and scaling of its platform.

“Our vision is to democratize surgery through advanced data by connecting every OR and Cath Lab in the world,” said CEO and founder Dr. Nadine Hatch-Haram in a statement.

“We started this journey by enabling surgeons to join virtually any OR. Now, we are using this capability to digitize operating rooms, bringing together the collective expertise of the world’s best surgeons in patients – where data collected and shared in Proximity helps them. Maybe life-saving care, no matter where they live. “


Digital Pathology Company Prussia announced on Tuesday that it had raised 37 37 million in Series C funding.

The round includes existing investors including Highline Capital Management, Triangle Peak Partners and Alpha Intelligence Capital, as well as scale investors including Scale Venture Partners, Hitachi Ventures, ROBO Global, Emerald Development Manager and Razors Edge Ventures.

Proscia said the investment brought its total growth to $ 72 million, building on one বি 23 million Series B round from 2020. It plans to use the funds to build its commercial activities, including hiring sales, marketing and support teams, as well as adding distribution partnerships.

“Pathology deserves the same revolutionary technology that has changed the rest of medicine and our lives,” CEO David West said in a statement. “Our Series C will enable us to continue providing this innovation to our scientists and pathologists who are using it to improve patient outcomes. We are thrilled to be partnering with incredible investors who are deeply confident in our goal as we take our next step.”

Leave a Reply

Your email address will not be published.